Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
39
days
Hearing Intervention for Older Adults With Mild Cognitive Impairment
Authors
Ying Chen; Haibo Shi; Mingliang Xiang; Xia Li; Zhili Wang; Wen Lu; Yilin Shen; Yuan Fang; Jie Chen; Lei Guan; Feifan Zhao; Zaichao Wu; Rong Tian; Qiongfei Yu; Kun Han; Haibin Sheng; Shengqi Chen; Jiayu Sun; Guangyu Liu; Hao WuShow moreShow less
Affiliations
1. Department of Otolaryngology-Head and Neck Surgery, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 2. Ear Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 3. Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases (14DZ2260300), Shanghai, China; 4. Department of Audiology & Speech-Language Pathology, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 5. Department of Otolaryngology-Head and Neck Surgery, Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 6. Department of Otolaryngology-Head and Neck Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 7. Department of Psychogeriatrics, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShow moreShow less
100
days
Common MC1R Variants and Parkinson Disease Progression
Authors
Jackson G. Schumacher; Xinyuan Zhang; Jian Wang; Johannes M. Dijkstra; Hirohisa Watanabe; Xiang Gao; Marianna Cortese; Eric A. Macklin; Michael A. Schwarzschild; Xiqun ChenShow moreShow less
Affiliations
1. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; 2. Aligning Science Across Parkinson’s Collaborative Research Network, Chevy Chase, Maryland; 3. Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; 4. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston; 5. Department of Neurology, School of Medicine, Fujita Health University, Toyoake, Japan; 6. Department of Nutritional Sciences, The Pennsylvania State University, University Park; 7. Now with Department of Nutrition and Food Hygiene, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, China; 8. Departments of Epidemiology and Nutrition, Harvard T. H. Chan School of Public Health, Boston, MassachusettsShow moreShow less
118
days
Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease
Authors
Clara Bueno Lopez; Andri Iona; Iain Turnbull; Huaidong Du; Yiping Chen; Ling Yang; Alexander Tinworth; Zhengjie Shen; Kshitij Kolhe; Pei Pei; Canqing Yu; Dianjianyi Sun; Jun Lv; Junshi Chen; Robert Clarke; Rory Collins; Richard Peto; Liming Li; Fiona Bragg; Zhengming ChenShow moreShow less
Affiliations
1. Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; 2. Noncommunicable Diseases Prevention and Control Department, Tongxiang Center for Disease Control and Prevention, Tongxiang, China; 3. Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China; 4. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China; 5. Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China; 6. China National Center for Food Safety Risk Assessment, Chaoyang District, Beijing, China; 7. Health Data Research UK Oxford, University of Oxford, Oxford, United KingdomShow moreShow less
66
days
Tirofiban for Branch Atheromatous Disease–Related Stroke
Authors
Yicong Wang; Xiaoling Liao; Shuo Feng; Yuesong Pan; Xuan Wang; Hui Qu; Yuetong Liu; Cong Gao; Xinru Liu; Qianqian Yang; Meiyang Zhang; Zhangxinyi Liu; Jinyi Ye; Yuke Mao; Weiqi Chen; Lingling Jiang; Philip M. Bath; S. Claiborne Johnston; Guillaume Turc; Xingquan Zhao; Yongjun Wang; Yilong WangShow moreShow less
Affiliations
1. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; 2. National Clinical Research Center for Neurological Diseases, Beijing, China; 3. Department of Neurology, Qilu Hospital of Shandong University, Jinan, China; 4. Stroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham, Nottingham, United Kingdom; 5. University of California, San Francisco; 6. INSERM U1266, Institute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, Paris, France; 7. GHU Paris Psychiatrie et Neurosciences, Paris, France; 8. National Center for Neurological Disorders, Beijing, China; 9. Research Unit of Artificial Intelligence in Cerebrovascular Disease, Chinese Academy of Medical Sciences, Beijing, China; 10. Advanced Innovation Center for Human Brain Protection, Beijing, China; 11. Beijing Laboratory of Oral Health, Beijing, China; 12. Chinese Institute for Brain Research, Beijing, China; 13. Laboratory for Clinical Medicine, Capital Medical University, Beijing, ChinaShow moreShow less
128
days
Management of Exacerbations and Rescue Therapy in the Phase 3 Myasthenia Gravis Inebilizumab Trial
Authors
Richard J. Nowak; Kimiaki Utsugisawa; Michael Benatar; Emma Ciafaloni; M. Isabel Leite; John Vissing; Fengming Tang; Yanping Wu; Catherine Najem; Sue Cheng; James F. HowardShow moreShow less
Affiliations
1. Program for Clinical and Translational Neuromuscular Research, Department of Neurology, Yale School of Medicine, Yale University, New Haven, Connecticut; 2. Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan; 3. Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida; 4. Department of Neurology, University of Rochester, Rochester, New York; 5. Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom; 6. Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 7. Rare Diseases Unit, Amgen, Thousand Oaks, California; 8. Department of Neurology, University of North Carolina, Chapel HillShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days